José
Palacios Calvo
Profesor/a Titular Universidad
David
Hardisson Hernáez
Publicaciones en las que colabora con David Hardisson Hernáez (37)
2024
-
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)
International Journal of Gynecological Pathology, Vol. 43, Núm. 5, pp. 436-446
2023
-
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
International journal of molecular sciences, Vol. 24, Núm. 13
2022
-
The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors
American Journal of Surgical Pathology, Vol. 46, Núm. 11, pp. 1545-1553
2020
-
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)
American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161
2018
-
Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)
Clinical and Translational Oncology
-
Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia
-
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 274-285
2011
-
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
EMBO Molecular Medicine, Vol. 3, Núm. 9, pp. 528-544
2009
-
Aurora kinases as prognostic biomarkers in ovarian carcinoma
Human Pathology, Vol. 40, Núm. 5, pp. 631-638
-
Tiling path genomic profiling of grade 3 invasive ductal breast cancers
Clinical Cancer Research, Vol. 15, Núm. 8, pp. 2711-2722
2008
-
Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma
PLoS ONE, Vol. 3, Núm. 12
-
Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen
Modern Pathology, Vol. 21, Núm. 8, pp. 925-936
-
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
Cancer Research, Vol. 68, Núm. 4, pp. 989-997
-
Molecular profiling pleomorphic lobular carcinomas of the breast: Evidence for a common molecular genetic pathway with classic lobular carcinomas
Journal of Pathology, Vol. 215, Núm. 3, pp. 231-244
2007
-
Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer
Cancer Research, Vol. 67, Núm. 5, pp. 1927-1934
-
Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer
Modern Pathology, Vol. 20, Núm. 4, pp. 474-481
-
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Journal of Clinical Pathology, Vol. 60, Núm. 9, pp. 1006-1012
2006
-
Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas
Breast Cancer Research and Treatment, Vol. 98, Núm. 1, pp. 71-79
-
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
Breast Cancer Research and Treatment, Vol. 99, Núm. 1, pp. 85-90
-
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas
Human Pathology, Vol. 37, Núm. 8, pp. 1042-1049